Literature DB >> 11105458

Osteoporosis.

T C Cymet1, B Wood, N Orbach.   

Abstract

Human bone thickness is genetically determined and influenced by lifestyle. Deterioration of bones affects the entire body's ability to function. Initially, osteoporosis is asymptomatic but may lead to bone fractures, altered mobility, and decreased functional ability. Identifying individuals at high risk for problems caused by low bone mass and evaluating bone density are key factors in fighting this major health problem. This article reviews the tests used to diagnose and follow the progression of the disease. It also discusses the benefits of vitamin D and calcium supplementation in bone formation and preservation, as well as treatment and prevention of osteoporosis.

Entities:  

Mesh:

Year:  2000        PMID: 11105458

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  4 in total

1.  Long noncoding RNA TRG-AS1 protects against glucocorticoid-induced osteoporosis in a rat model by regulating miR-802-mediated CAB39/AMPK/SIRT-1/NF-κB axis.

Authors:  Wen Liu; Guojuan Li; Jing Li; Wei Chen
Journal:  Hum Cell       Date:  2022-07-07       Impact factor: 4.374

2.  Effect of Different Anesthesia and Puncture Methods of Percutaneous Kyphoplasty on More Than 90-Year-Old Osteoporotic Vertebral Fracture: Advantages of the ERAS Concept.

Authors:  Hao Liu; Lei Deng; Jun-Xin Zhang; Quan Zhou; Zhong-Lai Qian; Chun-Yang Fan; Kang-Wu Chen; Hui-Lin Yang
Journal:  Int J Clin Pract       Date:  2022-05-09       Impact factor: 3.149

Review 3.  Advances in the application of mesenchymal stem cells, exosomes, biomimetic materials, and 3D printing in osteoporosis treatment.

Authors:  Xiao-Yu He; Hai-Ming Yu; Shu Lin; Yi-Zhong Li
Journal:  Cell Mol Biol Lett       Date:  2021-11-14       Impact factor: 5.787

Review 4.  The Improving Effect and Safety of Probiotic Supplements on Patients with Osteoporosis and Osteopenia: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.

Authors:  Liuting Zeng; Ganpeng Yu; Kailin Yang; Wensa Hao; Hua Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-24       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.